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Summary: Associations between the presence in HIV infected patients of 
different variants of HLA DRB1 locus alleles and the risk of HIV-associated 
diseases development while receiving HAART are determined. There is a 
correlation between HLA DRB1 locus alleles of histocompatibility class II and 
levels of β2-microglobulin, neopterin, immune cell activation and HIV load in 
patients receiving HAART. 
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It was shown that the increase in viral load (VL) may promote systemic 
activation of the immune system in HIV infection, which is a strong predictor of 
disease progression in HIV infection. It was proved that increased level of β2-
microglobulin (β2-MG) is associated with changes in the immune status and HIV 
viral load and is connected with HIV progression and survival of patients [2, 3]. 
There are literary data regarding positive associations of tuberculosis with 
specific HLA DRB1 locus that indicate susceptibility to tuberculosis [1]. 
Objective: Identify association between the presence of different variants of 
locus alleles of DRB1 in patients with HIV infection and the risk of HIV-
associated disorders and changes in immunological and virological parameters in 
patients receiving highly active antiretroviral therapy (HAART). 
Materials and methods. The study involved 102 patients with HIV aged 24 
to 58 years, the average age of patients was 38 years. The term of infection of 
examined subjects was in averaged 7.4 ± 0.33 years. According to the clinical 
course of HIV infection, all patients were divided into three groups. The 1
st
 group 
included 32 patients (31.4 %) with I and II clinical stages, the 2
nd
 group included 
26 (25.5 %) patients with clinical stage III, the 3
rd
 group included 44 (43.1%) 
patients with IV clinical stage. All patients were also divided into seven groups by 
the presence of locus alleles DRB1 of class II histocompatibility complex. Six 
research groups consisted of patients with alleles of genes that occur most 
frequently among persons in the Dnepropetrovsk region: HLA DRB1 *01, HLA 
DRB1 *04, HLA DRB1 *07, HLA DRB1 *11, HLA DRB1 *13, HLA DRB1 *15. 
The seventh group consisted of patients with alleles locus that is rarely found 
(HLA DRB1 *03, HLA DRB1 *08, HLA DRB1 *10, HLA DRB1 *12, HLA 
DRB1 *14, HLA DRB1 *16, HLA DRB1 *17, HLA DRB1 *18). Most examined 
patients (87.3%) received HAART for medical reasons, 12.7 % of patients in the 
study did not receive HAART for any other reason. The control group involved 15 
healthy donors. 
Specificities of 15 alleles of genes DRB1 were defined with amplified test 
systems. Determination of levels of neopterin (N) and β2-MG handled by ELISA 
with standard test systems (manufacturer Germany). 
Statistical analysis of the obtained material used the methods of Fisher 
criterion and Student's test. Value of p <0.05 was considered statistically 
significant. Statistical analysis of the results was performed using the software 
MathCad and Excel-2010. Considering the large range of VL data, for statistical 
analysis a log scale data were calculated. 
Results. According to our observations the highest percentage of occurrence 
of various forms of HIV-associated tuberculosis (TB), including first diagnosed 
tuberculosis (FDTB) observed in the lungs of patients with locus alleles HLA 
DRB1 *13 *15 and rarely seen locus alleles. Also various forms of TB in a smaller 
percentage of cases developed in patients with locus alleles HLA DRB1 *04 *07 
*11. TB never occurred in patients who had gene allele HLA DRB1 *01 (Table 1). 
Table 1. Dynamics of HIV-associated diseases in patients 
with different alleles of HLA DRB1 locus in patients receiving HAART 
Alleles 
HLA 
DRB1 
locus 
PGL, 
% 
Oropharyn
geal 
candidiasis
, % 
Recurrent 
bacterial 
infection of 
the URT, % 
Pneum
onia, 
% 
FDTB 
lung 
Various 
forms of 
TB, % 
Herpetic 
infection, 
% 
HLA 
DRB1 
*01 
31.6 67.7 31.6 31.6 - - - 
HLA 
DRB1 
*04 
43.6 87.5 37.5 - 31.3 - 37.5 
HLA 
DRB1 
*07 
- 50 37.5 - - 26.9 34.6 
HLA 
DRB1 
*11 
30.4 78.3 33.3 33.3 - 33.3 23.3 
HLA 
DRB1 
*13 
37.5 79.2 - 41.7 37.5 45.8 - 
HLA 
DRB1 
*15 
- 75 - - 50 50 - 
Rare 
alleles 
20 80 30 - 35 40 30 
Р  <0.004 <0.003 <0.004 <0.005 <0.003 <0.004 <0.005 
 
As shown in Table 1, recurrent bacterial infection of the upper respiratory 
tract (URT) occurred in patients with HIV locus with alleles HLA DRB1 *01, *04, 
*07, *11 and with rare alleles. Pneumonia developed in patients who have had 
locus alleles HLA DRB1 * 01, * 11, * 13. Concurrent herpetic infections in HIV-
infected patients occurred in the presence of gene alleles HLA DRB1 *04 *07 *11 
and rare alleles of locus. In HIV-infected examined patients of all groups 
regardless of the system of HLA DRB1 HIV-associated oropharyngeal candidiasis 
developed. Persistent generalized lymphadenopathy (PGL) was seen in HIV 
infected patients with locus alleles HLA DRB1 *01 *04 *11 *13 and rare alleles. 
 
Table 2. Dynamics of disease development in HIV-infected patients with 
different locus alleles of HLA DRB1 in patients receiving HAART 
Alleles HLA 
DRB1 locus 
CHCV, % CHBV, % CH  
unspecified 
(including toxic 
hepatitis), % 
Cirrhosis, 
% 
Anemia I, II, 
III degree, % 
HLA DRB1 
*01 
63 42 84 - - 
HLA DRB1 
*04 
68.7 43.8 81.3 31.3 56.3 
HLA DRB1 
*07 
41.7 - 58.3 - - 
HLA DRB1 
*11 
60.8 34.8 78.3 - 52.2 
HLA DRB1 
*13 
62.5 - 79.2 - 33.3 
HLA DRB1 
*15 
50 - 66.7 - - 
Rare alleles 52.5 37.5 72.5 - 30 
Р  <0.004 <0.003 <0.005 <0.004 <0.003 
 
Chronic viral hepatitis C (CHCV) and chronic hepatitis (CH) unspecified 
(including toxic hepatitis) as concomitant disease, developed in HIV-infected 
patients irrespective of HLA class II. Chronic viral hepatitis B (CHВV) occurred in 
patients with gene alleles HLA DRB1 *01, *04, *11 and rare alleles. CH 
progressed into cirrhosis in patients with locus alleles HLA DRB1 *04. Anemia I, 
II, III degree accompanies patients with HIV infection who have locus alleles HLA 
DRB1 *04, *11, *13 and rare alleles. (Table 2) 
 
Table. 3. Dynamics of biochemical and immunological parameters in HIV-
infected patients with different locus alleles DRB1 II class while taking HAART 
Alleles of 
HLA 
DRB1 
locus 
Groups 
of 
patients 
N,  
nmol/l 
β2-MG,  
mcg/ml 
CD4
+  
T-helper 
cells 
Р  
HLA 
DRB1 
*01 
І 33.444±29.479 6.578±1.676 426 ±185 <0.003 
ІІ 53.5±3.536 9.25±0.355 340±4.95 <0.006 
ІІІ 56.714±10.847 9.429±1.117 323±200 <0.004 
HLA 
DRB1 
*04 
І 65±42.509 9.2±45.197 428±115 <0.003 
ІІ 68.4±1.709 9.44±2.389 422±184 <0.006 
ІІІ 77.125±10.062 25.039±1.432 127±123 <0.004 
HLA 
DRB1 
*07 
І 29.125±14.055 7.05±1.623 552±191 <0.003 
ІІ 53.333±33.399 8.6±2.245 279±59 <0.006 
ІІІ 50±10.583 8.14±0.876 193±89 <0.004 
HLA 
DRB1 
*11 
І 24±9.899 6.45±0.636 468±145 <0.003 
ІІ 56.222±14.292 9.389±1.013 359±86 <0.006 
ІІІ 68.1±30.658 10.06±1.831 130±92 <0.004 
HLA 
DRB1 
*13 
І 46±9.077 8.3±1.011 533±238 <0.003 
ІІ 56.333±37.033 8.7±2.573 387±146 <0.006 
       ІІІ 61.083±24.839 9.042±1.215 171±129 <0.004 
HLA 
DRB1 
*15 
       І 31.875±13.943 7.238±1.48 551±172 <0.003 
       ІІ 79±8.888 9.663±1.212 211±69 <0.006 
       ІІІ 83±33.141 9.757±1.427 201±201 <0.004 
Rare 
alleles 
       І 31±12.423 7.757±1.176 447±183 <0.003 
       ІІ 50±20.255 8.531±1.284 344±117 <0.006 
       ІІІ 74.706±32.247 9.641±1.855 162±130 <0.004 
 
As shown in Tables 3, 4 in almost all patients in all examined groups there 
was an increase in VL, reduced levels of CD4 + T-helper cells and increased levels 
of N and β2-MG in the development of HIV from I till IV clinical stages in 
patients receiving HAART. 
 
Table. 4.Dynamics of changes in viral load in HIV-infected patients with 
different gene alleles DRB1 II class on HAART 
In patients with the allele HLA DRB1 *01 reduction in VL 1.8-fold 
(between I and III groups) was observed and CD4+ T-helper cells were kept at a 
high level (up to 323±200) even taking into account the stage of HIV infection that 
was not observed in other alleles of the HLA DRB1 gene. In all other patients who 
had the allele HLA DRB1 locus *04, *07, *11, *13, *15 and rare alleles with IV 
clinical stage CD4+ T-helper cells were decreased to the level of ≤200 in 1 mm3 
and VL was increased 1.2 – 2.1 times. Increased levels of N and β2-MG were 
Alleles HLA 
DRB1 locus 
Groups of 
patients 
VL (ln) Р  
HLA DRB1 *01 І 4.325±3.433 <0.004 
ІІ 3.689 <0.007 
ІІІ 2.405±5.753 <0.005 
HLA DRB1 *04 І 3.689 <0.004 
ІІ 4.677±3.047 <0.007 
ІІІ 7.461±4.423 <0.005 
HLA DRB1 *07 І 4.359±2.085 <0.004 
ІІ 4.144±1.991 <0.007 
ІІІ 5.583±2.81 <0.005 
HLA DRB1 *11 І 3.924±0.332 <0.004 
ІІ 5.661±2.942 <0.007 
ІІІ 7.486±4.377 <0.005 
HLA DRB1 *13 І 4.619±2.168 <0.004 
ІІ 7.767±2.857 <0.007 
ІІІ 5.292±2.127 <0.005 
HLA DRB1 *15 І 6.216±3.632 <0.004 
ІІ 8.154 <0.007 
ІІІ 8.154±4.327 <0.005 
Rare alleles І 5.064±3.074 <0.004 
ІІ 4.008±0.625 <0.007 
ІІІ 7.16±4.139 <0.005 
observed in all patients with different alleles of the HLA DRB1 locus. However, 
the most significant increase in both N and β2-MG was seen in carriers of alleles 
of the locus HLA DRB1 *01, *11, *15. Thus, at HLA DRB1 *01 N was increased 
1.7 times, β2-MG by 1.4 times; in HLA DRB1 *11 N was increased 2.8 times, β2-
MG is 1.6; with HLA DRB1 *15 N was increased 2.6 times, β2-MG 1.4 times. A 
separate significant 1.7 times increase of N was observed in patients with alleles of 
the locus HLA DRB1 *07 and in rare alleles 2.4 times. A separate and significant 
increase of β2-MG 2.7 times was observed in patients who had the alleles of the 
locus HLA DRB1 *04. 
Conclusions. 
1. There was a correlation between alleles of DRB1 locus of HLA 
histocompatibility class II and β2-MG, N, cellular immune activation and HIV 
load in patients receiving HAART.  
2. In the process of receiving HAART in patients with alleles of the locus 
HLA DRB1 *01 there was observed the 1.8 times decrease of VL, the content of 
CD4+ T-helper cells at a sufficiently high level, even taking into account the stage 
of HIV infection that was not observed in other alleles of the HLA DRB1 gene. 
With the alleles of the locus HLA DRB1 *04, *07, *11, *13, *15 and rare alleles 
even with HAART there was a sharp decrease in CD4+ T-helper cells to the level 
of ≤200 in 1 mm3 and an increase in VL.  
3. Increased levels of N and β2-MG were observed in all patients with 
different alleles of the HLA DRB1 locus. However, the most significant increase in 
both N and β2-MG was seen in alleles of the locus HLA DRB1 *01, *11, *15.  
4. The highest percentage of occurrence of HIV-associated TB of various 
forms, including FDTB lung was observed in patients with alleles of the locus 
HLA DRB1 *13, *15 and with rare alleles. Also TB of various forms in a smaller 
percentage of cases developed in patients with alleles of the locus HLA DRB1 *04, 
*07, *11. In patients who had the allele of gene HLA DRB1 *01 TB did not 
develop.  
5. Pneumonia developed in HIV-infected patients who had alleles of the 
locus HLA DRB1 *01, *11, *13.  
6. The development of herpetic infection in HIV-infected patients occurred 
in the presence of gene HLA DRB1 alleles *04, *07, *11 and rare alleles.  
7. Chronic HCV and chronic hepatitis unspecified (including toxic hepatitis) 
as a concurrent disease developed in HIV-infected patients regardless of the HLA 
class II. Chronic HBV was seen in patients with HLA alleles DRB1 *01, *04, *11, 
and rare alleles. Chronic hepatitis progressed to cirrhosis in patients with alleles of 
the locus HLA DRB1 *04. 
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